Virbac Share Information and Voting Rights Overview
The declaration of shares and voting rights is a vital aspect of corporate transparency for investors and stakeholders. Recently, Virbac has provided significant details regarding the total number of shares and the associated voting rights as per regulatory requirements. This information is crucial for shareholders to understand their stake in the company and influence corporate governance.
Understanding the Number of Shares and Voting Rights
In accordance with Article 223-16 of the French Financial Market Authority regulations, companies must disclose the total number of shares representing their capital and the total number of voting rights. This ensures that all investors have access to the same information, enabling them to make informed decisions.
As for Virbac, the total number of shares representing the share capital stands at approximately 8,390,660 shares. This not only reflects the company’s growth but also provides a basis for the calculation of voting rights, which are pivotal during annual general meetings and other shareholder votes.
Detailed Share and Voting Rights Information
The latest figures indicate that the gross total of voting rights is around 12,707,315. However, it’s important to note that the net total of voting rights accounts for shares that do not carry voting rights, which results in a net total of approximately 12,691,249. This net calculation is essential for shareholders who need to know the actual influence their shares can exert within the company.
What Does Net Total Mean?
The term 'net total' refers to the number of voting rights after subtracting any shares that do not provide voting privileges. This figure gives investors a clearer picture of their voting capacity based on the shares they hold.
Virbac: A Leader in Animal Health
Virbac, recognized for its immense contributions to the field of animal health, has continuously strived to innovate and deliver quality products. The company is committed to enhancing the well-being of animals worldwide, reflecting in their responsible governance and share handling. It's important for shareholders to observe how these factors contribute to Virbac's overall market performance.
Virbac's shares are traded on NYSE Euronext under the ISIN code FR0000031577 and the MNEMO code VIRP. Their consistent performance on the stock market showcases the trust investors place in the company's business strategies and market positioning.
Contacting Virbac for More Information
If stakeholders have further inquiries regarding their shares or voting rights, they can easily reach the corporate finance team at 33 4 92 08 71 32 or via email at finances@virbac.com. Moreover, the company maintains an extensive online presence at www.virbac.com, providing valuable resources and updates.
Frequently Asked Questions
1. What is the total number of shares that Virbac currently has?
Virbac currently has approximately 8,390,660 shares representing its share capital.
2. How many voting rights does each share provide?
The gross total of voting rights is 12,707,315, but after accounting for non-voting shares, the net total is around 12,691,249 voting rights.
3. Why is it important to know the net total of voting rights?
The net total gives an accurate representation of how many votes shareholders can cast, impacting decisions in corporate governance.
4. How can I contact Virbac for financial inquiries?
Shareholders can contact Virbac's corporate finance team by phone at 33 4 92 08 71 32 or via email at finances@virbac.com.
5. Where can I find more information about Virbac's financial reports?
More financial information and updates can be found on Virbac's official website at www.virbac.com.
